EXCLUSIVE: MIRA Pharmaceuticals’ Disruptive Path In Neurology And Metabolic Disorders
CEO Erez Aminov on Breakthrough Drug Candidates, Strategic Acquisitions, and the Vision Behind MIRA’s Innovation-Driven Pipeline MIRA Pharmaceuticals (NASDAQ: MIRA), ...